Abstract
The serotonin transporter (5-HTT) is a key molecule of serotoninergic neurotransmission and target of many anxiolytics and antidepressants. In humans, 5-HTT gene variants resulting in lower expression levels are associated with behavioral traits of anxiety. Furthermore, functional magnetic resonance imaging (fMRI) studies reported increased cerebral blood flow (CBF) during resting state (RS) and amygdala hyperreactivity. 5-HTT deficient mice as an established animal model for anxiety disorders seem to be well suited for investigating amygdala (re-)activity in an fMRI study. We investigated wildtype (5-HTT+/+), heterozygous (5-HTT+/-), and homozygous 5-HTT-knockout mice (5-HTT-/-) of both sexes in an ultra-high-field 17.6 Tesla magnetic resonance scanner. CBF was measured with continuous arterial spin labeling during RS, stimulation state (SS; with odor of rats as aversive stimulus), and post-stimulation state (PS). Subsequently, post mortem c-Fos immunohistochemistry elucidated neural activation on cellular level. The results showed that in reaction to the aversive odor CBF in total brain and amygdala of all mice significantly increased. In male 5-HTT+/+ mice amygdala RS CBF levels were found to be significantly lower than in 5-HTT+/- mice. From RS to SS 5-HTT+/+ amygdala perfusion significantly increased compared to both 5-HTT+/- and 5-HTT-/- mice. Perfusion level changes of male mice correlated with the density of c-Fos-immunoreactive cells in the amygdaloid nuclei. In female mice the perfusion was not modulated by the 5-Htt-genotype, but by estrous cycle stages. We conclude that amygdala reactivity is modulated by the 5-Htt genotype in males. In females, gonadal hormones have an impact which might have obscured genotype effects. Furthermore, our results demonstrate experimental support for the tonic model of 5-HTTLPR function.
Introduction
The monoamine serotonin (5-hydroxtryptamine, 5-HT) is one of the key modulators of emotional states and cognitive processing. The 5-HT transporter (5-HTT) responsible for the re-uptake of synaptically released 5-HT into the presynaptic neuron is important for the fine-tuning of serotonergic neurotransmission and is a principal target of various antidepressants and anxiolytics [1–3]. In humans, variation of 5-HTT/SLC6A4 gene expression levels are mainly genetically driven by the 5-HTT gene-linked polymorphic region (5-HTTLPR) in the promotor. The short (S)-allele results in lower 5-HTT mRNA and protein levels and is shown to be associated with an increased risk for affective disorders and maladaptive behavioral traits [4–7]. Additionally, a single-nucleotide polymorphism in the long (L) variant affects 5-HTT availability with the LG variant resulting in nearly equivalent expression levels as the S variant [8].
To further deepen the knowledge of the influence of altered 5-HT neurotransmission on neurodevelopment and behavior the 5-HTT knockout (-/-) mouse model with a targeted disruption of the 5-Htt gene was generated [9]. 5-HTT-deficient mice exhibit many changes at the neurochemical/5-HT receptor level [10–14], display increased anxiety-related behavior [15,16] and altered stress susceptibility [17,18], and therefore are established as an animal model for anxiety disorders and for 5-Htt gene-by-environment interaction studies[19–21]. A previous study shows that olfactory perception is unaltered in 5-HTT-deficient mice [22].
Understanding of fear and anxiety disorders requires the elucidation of networks and processes that convert an aversive stimulus into a fear reaction irrespective of whether it is appropriate or not. The anxiety/fear network comprises several directly or indirectly connected regions and nuclei, including the amygdala, prelimbic and infralimbic cortex, bed nucleus of stria terminalis, hippocampus, and periaqueductal grey including the raphe nuclei [for review [23]]. Our research mainly focuses on the amygdala, as it is an important key player in the neurocircuitry of fear, stress, and anxiety disorders [24]. The amygdala, a complex structure consisting of several interconnected nuclei, receives numerous afferents from different brain regions including serotonergic afferents primarily originating in neurons of the dorsal and sparsely originating in neurons of the median raphe nuclei [25–27]. The two main sub-areas of the amygdala are the striatum-like central nucleus of the amygdala (Ce) composed mainly of GABAergic neurons and the cortex-like basolateral amygdala (BLA) with around 80% glutamatergic principal neurons and roughly 20% GABAergic interneurons. The BLA is composed of the lateral (La) and basolateral (BL) nucleus [28,29].
Several behavioral responses important for the survival and reproduction of an organism like feeding, mating and escaping are known to be initiated and driven by odors. The medial nucleus of the amygdala receives olfactory information either by the vomeronasal or the main olfactory system [30–33] Chemosensory information from both pathways is further transferred to the hypothalamus, nucleus accumbens and to the Ce and BLA [34]. Mice that are exposed to rat predator scents exhibit innate defensive behaviors including flight and freezing as well as an increase in stress hormone levels [35–39]. Furthermore, predator odors were shown to evoke an increase in the immediate early gene (IEG) product c-Fos in the BL, Ce and medial nucleus in rodents [40–42]. Increase in c-Fos protein expression occurs in response to direct stimulation of neurons and serves as marker for neuronal activation [43–45].
In human fMRI studies, increased resting cerebral blood flow (CBF) in the amygdala and hippocampus of healthy 5-HTT/SLC6A4 S-allele carriers compared to L-allele carriers was demonstrated first by Canli and coworkers using arterial spin labeling (ASL) [46]. These findings were independently replicated for the amygdala using continuous ASL (CASL), whereas no difference in global CBF intensities was found across the two genotype groups [47]. Controversially to all these findings, Viviani and coworkers did not reveal an association between the 5-HTTLPR polymorphism and baseline brain perfusion in a cohort of 183 healthy individuals appying CASL [48].
Applying another technique, the blood oxygen level dependent (BOLD) contrast imaging, healthy individuals with one or two copies of the S allele exhibited greater BOLD signal change in the amygdala in response to the presentation of fearful and angry faces indicating increased neuronal activity in the amygdala of S allele carriers compared to the homozygous L allele group [[49–53] for review: [54,55]]. Results of 99mTc-HMPAO-SPECT scans performed with patients suffering from major depression also pointed to an over(re)activity of the amydalae of the S-allele group relative to the L/L group [56].
Amygdala activity and reactivity to negative stimuli can be investigated in mice, as in humans, with the CASL method using magnetically labelled blood as an intrinsic marker to measure perfusion and signal changes in specific brain regions [57]. In the present study, the CASL approach was applied using an ultra-high-field 17.6 Tesla magnetic resonance imaging (MRI) system to investigate CBF and predator odor-induced perfusion changes in the amygdala and whole brain of male and female mice of different 5-Htt genotypes. As a marker for perfusion this study uses a perfusion level that indicates the proportion of perfusion relative to the overall signal intensity of each voxel, which represents a much less intereference-prone parameter. This approach extensively excludes any preexisting and constant conditions like subject specific blood supply, which might influence the measurements. Subsequently, quantitative immunohistochemistry for c-Fos was carried out to assess amygdala activation at the cellular level, combining, for the first time, ultra-high-field MRI at 17.6 T and IEG-based cellular activation mapping strategies. We hypothesized that rat odor-induced perfusion level changes and c-Fos-immunoreactivity in the rodent amygdala are differentially affected by 5-Htt genotype and sex.
Material and methods
Ethics statement
The present work complies with current regulations regarding animal experimentation in Germany and the EU (European Communities Council Directive 86/609/EEC). All procedures and protocols have been approved by the committees on the ethics of animal experiments of the University of Würzburg and of the Government of Lower Franconia (license 55.2–2531.01-81/10). Sacrifice was performed under deep isoflurane anesthesia. All efforts were made to minimize suffering.
Animals
Experimental subjects were 3–6 month-old 5-HTT homozygous knockout (5-HTT-/-), heterozygous knockout (5-HTT+/-) and wildtype (5-HTT+/+) mice originating from heterozygous mating pairs fully backcrossed onto C57BL/6J genetic background [9]. All animals were bred and housed in the animal facility of the Center for Experimental Molecular Medicine at the University of Wuerzburg under controlled conditions (12/12 h light-dark cycle, 21±1°C room temperature and 55±5% relative humidity) and with food and water provided ad libitum. Mice were genotyped by PCR using genomic DNA extracted from ear tissue.
Functional magnetic resonance imaging
General procedure
FMRI experiments were performed at the Department of Experimental Physics 5 (University of Wuerzburg) in cooperation with the Fraunhofer Development Center X-Ray Technology EZRT, Department of Magnetic Resonance and X-Ray Imaging on a wide-bore ultra-high-field magnet at 17.6 T (Bruker Avance 750 WB, Bruker BioSpin GmbH, Ettlingen, Germany) with a Bruker Mini 0.75 (300 mT/m) gradient system. As displayed in Table 1 fMRI was conducted on 29 male and 28 female mice that were exposed to rat odor as an unconditional fear-evoking stimulus. A subgroup of these mice was then used to evaluate the induction of c-Fos immunoreactivity in the amygdala. In addition, some mice (male: n = 3; female: n = 4) were exposed to a neutral odor and thus served as a negative control of c-Fos induction by rat odor.
Table 1. Age, body weight and number of mice used in fMRI and c-Fos experiments.
Male | Female | |||||
---|---|---|---|---|---|---|
+/+ | +/- | -/- | +/+ | +/- | -/- | |
Age [mo, mean (min-max)] | 4.9 (3.5–6.1) | 5.4 (4.0–6.1) | 5.0 (3.6–5.9) | 5.4 (5.1–5.6) | 5.4 (5.0–5.6) | 5.4 (5.2–5.6) |
BW [g, mean±SEM] | 32.0 ± 1.3 | 33.9 ± 1.1 | 34.8 ± 1.6 | 24.4 ± 0.7a | 25.6 ± 0.9a | 29.9 ± 1.1b |
fMRI [n] | 8 | 9 | 12 | 9 | 9 | 10 |
c-Fos [n] | 4 | 4 | 6 | 2 | 2 | 2 |
BW, body weight; mo, months; g, grams; n, number of mice
a: p<0.05 vs.
b. Additional control mice (neutral odor): 5-HTT+/+: male (n = 1), female (n = 1); 5-HTT+/-: male (n = 1); female (n = 1); 5-HTT-/-: male (n = 1), female (n = 2).
Animals were transported to the location with the 17.6 T scanner 24 h prior to the experiment to allow adaptation to the new environment to reduce stress.
All fMRI measurements were performed during the light phase between 9 AM and 7 PM. Males and females were tested independently, and the testing order was continuously alternated between the three genotypes to prevent potential time-of-day effects. Moreover, to control for sex hormone fluctuations in female mice, the individual estrous cycle stage was determined cytologically as described by McLean and coworkers directly before fMRI [58].
Odor preparation
Rat odor administered during fMRI was prepared from a 50 ml tube filled with male rat soiled bedding moistened with water and stored at -20°C to prevent loss of odorous substance. The frozen bedding was slowly defrosted right before initiation of the measurement. Neutral control odor was prepared the same way, but with unused bedding material.
Animal preparation
Mice were pre-anesthetized in their home cages with an induction level of 0.8% isoflurane (Forene®, Abbott, Switzerland) in compressed air (1.0 l/min) to prevent pre-experimental stress through slow sleep induction. The isoflurane concentration was then elevated to 4.0% by volume for up to 10 min to ensure deep anesthesia, important for subsequent fixation of the mice in supine position in a custom-made holder. Mice were fixed at four locations to prevent head movements in the scanner: Both ears with cotton buds, back of the head on a locating surface and teeth with a strand loop. The holder was positioned in a 38 mm diameter birdcage coil, which was used for radio-frequency transmission and signal reception. The percentage of isoflurane was decreased to 1.0% to maintain lower anesthesia during the experiment.
Vital sign monitoring
Respiration and heart rate were monitored throughout the experiment using an air-balloon positioned ventrally underneath the mouse thorax. The active temperature control of the MRI gradient system was used to maintain a constant environmental temperature of 37°C, which was monitored by a thermal sensor in the gradient system.
Experimental procedure
Structural and functional images of individual mice were registered onto a reference image selected from the measurements on the criteria of similarity to the image of the Allen Brain Mouse Atlas of the same sectional plane. This was done to compensate for anatomical- and geometrical-dependent differences between the subjects and to use one uniform regions of interest (ROI) layout in order to eliminate the error of individual ROI drafting.
The experimental procedure consisted of eight 10 min perfusion measurement blocks each comprising of 10 labeled and 10 unlabeled MRI acquisitions. As displayed in Fig 1, three 10 min blocks were acquired during the resting state (RS), two blocks during the stimulation state (SS) and three blocks during the post-stimulation state (PS). To prevent habituation, rat (or neutral) odor was applied automatically every two seconds as an air blast of one second duration by adding it to the constant stream of air/isoflurane-mixture during SS. Two hours after SS onset, mice were sacrificed, according to IACUC standards, by cervical dislocation following a deep anesthesia with isoflurane. Brains were then immediately dissected and processed for subsequent c-Fos immunohistochemical analyses.
Perfusion MRI with continuous arterial spin labeling
CASL measurements were performed with a modified single coil method using a turbo spin-echo imaging sequence [59–61] already described as applicable for perfusion measurements in animal models of ischemic stroke [62]. CASL parameters are described in detail by Pham and coworkers [63]. An in-house built transmit/receive linear birdcage resonator coil with an inner diameter of 38 mm was used.
Rostral to caudal adjustment of the image plane for perfusion measurements was accomplished with coronal orientated scout images [Rapid Acquisition with Refocused Echoes (RARE), echo train length (ETL) = 20, effective echo time TEeff = 9.43 ms, repetition time TR = 7.5 s, slice thickness = 1.0 mm, number of slices = 3, field of view (FOV) = 4.0×4.0 cm, matrix of 180×180 voxels] for each animal to assure that most parts of the amygdala were within the measuring plane. The aim was to adjust the head of the mouse in a position so that the scout image was at the best rate equivalent to Bregma level -1.22 mm [64].
A radio frequency (RF) pulse located 1.4 cm away from the imaging plane based on the tagging-gradient was applied for the adiabatic inversion of arterial blood in the neck. Compensation of magnetization transfer effects was achieved by reversing the tagging-gradient before acquisition of the corresponding non-inverted control image.
RARE parameters were: ETL = 8, TEeff = 28.88 msec, TR = 1.0 sec, slice thickness = 1.5 mm, FOV = 1.68×1.68 cm with a matrix of 64×64 voxels. Alternating acquisition of measurements with the blood being labeled and unlabeled was repeated 10 times, resulting in a block measurement time of 10 min. All acquisitions were post-processed using MATLAB® (The Mathworks Inc., Natick, MA, USA). Images were screened for artifacts e.g. reflecting mouse head movements to prevent distorted perfusion measurements. The block-wise averaged labeled and unlabeled images were subtracted from each other and the difference representing the perfusion was then divided by the unlabeled image to finally obtain the perfusion level. The signal intensity of the unlabeled images is proportional to the amount of protons (e.g. blood) which is influenced by all kind of effects that target blood and water content as well as influences such as receiver amplification and field homogeneity which may differ for each measurement. The perfusion level indicates the proportion of perfusion relative to the overall signal intensity of each voxel, which represents a much less intereference-prone parameter. This approach extensively excludes any preexisting and constant conditions like subject specific blood supply, which might influence the measurements.
These block-wise maps were averaged again for each state to create one map per state. In order to eliminate differences in brain geometry, an anatomic image of each mouse underwent an image registration with the algorithm of Periaswamy and Farid [65,66]. The individual registration vector map was then applied to all corresponding images and maps in order to use one ROI layout for all mice to minimize inter-individual errors.
Both, percental perfusion level changes from RS to SS and SS to PS were calculated for each animal using following calculation: SS/RS x 100 or PS/SS x 100.
Image analysis
ROIs, i.e. total brain and the amygdaloid region comprising La, BL and Ce (termed as “amygdala” in the following), were defined in the consolidated image of all registered mouse brains as indicated in the mouse brain atlas of Franklin and Paxinos at Bregma level -0.94 mm to -1.82 mm (see Fig 2) [64].
Quantitative immunohistochemistry for the detection of c-Fos protein
Tissue preparation
Brains were fixed in 4% PFA (dissolved in 1xPBS, pH 7.5) for 48 h. After treatment with sucrose brains were frozen in dry ice cooled isopentane and stored at -80°C. Finally, they were cut into coronal sections of 50 μm thickness, subsequently split into 6 series (each consisting of up to 7 slices with amygdala), and preserved in a cryoprotectant solution at -20°C for later use.
c-Fos immunohistochemistry
c-Fos immunohistochemistry was performed using the polyclonal antibody against c-Fos (made in rabbit, Santa Cruz, 1:8000; sc-52; unfortunately, this antibody has been discontinued in the meantime), applying the ABC method and 3,3´-diaminobenzidin as the substrate of the peroxidase according to the procedure described by [18]. No-Primary-Controls with omitting primary antibody incubation were performed and always resulted in the absence of any staining. In addition, positive-tissue-controls had been performed to verify the specifity of c-Fos immunoreactivity at the sub-cellular, cellular, and regional level.
Quantification of c-Fos-immunoreactive cells
For quantitative estimation of c-Fos-ir cells the Stereo Investigator 11 software was used in combination with a Neurolucida Microscope system from MBF Biosciences (Williston, USA). The experimenter blind for the 5-Htt genotypes individually traced the area of La, BL, and Ce, counted c-Fos-immune-positive cells, and calculated the relative cell density (cells per μm2). Finally, c-Fos-ir cell densities of every section were averaged for each animal.
Data analysis
All data were analyzed using SPSS Statistics version 23 (IBM Corporation, New York, USA). GraphPad Prism software version 6 (GraphPad Software, La Jolla, California, USA) was used for data graphing.
Comprehensive preliminary analyses were carried out to determine whether data met the assumptions of parametric tests. Data sets were visually inspected via boxplots to examine symmetry, skew, variance and outliers. Additionally, the Shapiro-Wilk test of normality and Levene’s test for homogeneity of variances were performed (S1 and S3 Tables). In ANOVAs with repeated measures Mauchly’s test was applied to determine whether the assumption of sphericity has been met. Cerebral perfusion level data obtained from CASL-based fMRI scans were analyzed by two-way mixed ANOVA with 5-Htt genotype as between-subjects factor and phase (RS, SS, PS) as within-subjects factor. In females, estrous cycle (proestrus vs. other stages) was included as an additional between-subjects factor. Relative perfusion level changes across the distinct fMRI phases were calculated as a fraction of one another (SS/RS, PS/RS, PS/SS) and analyzed by regular ANOVAs with genotype (and estrous cycle in females) as factor(s). The same statistical procedure was applied for the analysis of c-Fos-ir cell densities in the amygdala. Significant interactions were followed up with simple main effects analyses and Bonferroni post hoc tests for pairwise comparisons. Where applicable, Welch’s ANOVA and Games-Howell post-hoc tests were used.
The Pearson correlation coefficient was performed to determine the relationship between rat odor-induced amygdala perfusion levels and c-Fos-ir cell densities in the La, BL and Ce.
The chi-square test was used to check whether the two variables estrous cycle stage and 5-Htt genotype are statistically independent.
Data are shown as means ± standard errors of the mean (SEM) unless stated otherwise. Significance levels are indicated as #p<0.1, *p<0.05, **p<0.01 and ***p<0.001.
Results
Resting state perfusion and odor-induced perfusion level changes in the amygdala of male mice are influenced by 5-Htt genotype
Statistical results are summarized in S1 Table. Two-way mixed ANOVA on local perfusion in the amygdala of males (Fig 3A) yielded a strong main effect of phase (F(2,52) = 35.626, p<0.0001) along with a significant phase x genotype interaction (F(4,52) = 2.611, p = 0.046). Simple main effects analyses showed that, on the one hand, the interaction was driven by a strong genotype effect on RS perfusion (F(2,15.9) = 6.810, p = 0.007). Post hoc tests revealed significantly elevated RS perfusion levels in 5-HTT+/- mice as compared to 5-HTT+/+ (p = 0.012; brackets with dashed lines in Fig 3A). 5-HTT-/- mice exhibited intermediate RS perfusion values that were indistinguishable from those of 5-HTT+/- and 5-HTT+/+ littermates (p = 0.176 and p = 0.148, respectively). Neither SS nor PS perfusion levels differed among 5-Htt genotypes (F(2,15.3) = 1.743, p = 0.208 and F(2,26) = 0.936, p = 0.405, respectively). On the other hand, the interaction could be explained by a genotype-dependent difference in the magnitude of odor-induced signal change. Specifically, the increase in amygdala perfusion upon odor stimulation (RS→SS) was highest in 5-HTT+/+ (p<0.0001), intermediate in 5-HTT-/- (p = 0.009) and lowest in 5-HTT+/- (p = 0.069) mice. Similarly, PS perfusion level was significantly elevated above baseline (RS→PS) in 5-HTT+/+ (p<0.0001), 5-HTT-/- (p<0.0001) and 5-HTT+/- (p = 0.023) mice.
Accordingly, when SS and PS perfusion levels were expressed as a fraction of resting state perfusion level (SS/RS and PS/RS, respectively), ANOVA detected a highly significant genotype effect on both SS/RS (F(2,26) = 5.848, p = 0.008) and PS/RS (F(2,26) = 7.201, p = 0.003). Post-hoc tests indicated that both measures were significantly increased in 5-HTT+/+ mice relative to 5-HTT+/- (p≤0.01) and 5-HTT-/- (p<0.05) littermates (Fig 3B and 3C). Conversely, the PS/SS ratio did not significantly differ between genotypes (F(2,26) = 0.112, p = 0.894). Fig 3D visualizes percental signal changes from RS to SS, as individual percental signal changes were calculated for each voxel in the ROI amygdala and according to their value they were plotted in the corresponding intensity.
Analysis of whole-brain perfusion yielded a highly significant main effect of phase (F(2,52) = 46.573, p<0.0001), but no genotype main effect (F(2,26) = 3.031, p = 0.066) or an interaction between these two factors (F(4,52) = 1.860, p = 0.131; S1 Fig, S1 Table).
Odor-induced c-Fos immunoreactivity in the amygdala of male mice is influenced by 5-Htt genotype
Amygdalar cellular activation upon rat odor exposure during fMRI scans was assessed by quantitative analysis of c-Fos-ir cells in the La, BL and Ce of male mice two hours after stimulus onset (Fig 4C, 4E and 4G). We detected significant genotype effects on c-Fos-ir cell density in all three subnuclei (La: F(2,6.09) = 6.530, p = 0.031; BL: F(2,11) = 15.594, p = 0.001; Ce: F(2,11) = 8.881, p = 0.005). Post hoc tests indicated significantly increased c-Fos immunoreactivity in the amygdala of 5-HTT+/+ mice compared to 5-HTT+/- (La: p = 0.053, BL: p = 0.003, Ce: p = 0.016) and 5-HTT-/- (La: p = 0.040, BL: p = 0.001, Ce: p = 0.007) littermates.
Positive correlation of the density of c-Fos-immunoreactive cells and perfusion level changes points to an important relationship between perfusion and neuronal activity
Analyzing possible correlations between percental increase of perfusion from RS to SS (SS/RS perfusion level) and c-Fos-ir cell density in the amygdala resulted in a moderate, positive correlation, which was significant for La (r(13) = 0.630, p = 0.021; Fig 4D), BL (r(13) = 0.798, p = 0.001; Fig 4F) and Ce (r(13) = 0.583, p = 0.037; Fig 4H). Moreover, PS/RS perfusion correlated significantly with c-Fos-ir cell density in all three amygdala subnuclei (La: r(13) = 0.594, p = 0.032, BL: r(13) = 0.695, p = 0.008, Ce: r(13) = 0.587, p = 0.035).
Estrous cycle stage determination
The four different estrous cycle stages (proestrus, estrus, metestrus, diestrus) were fairly equally distributed across genotypes (χ2(6) = 5.527, p = 0.478; n = 28; S2 Table). Overall, however, the proestrus stage greatly predominated over the other stages (χ2(3) = 20.571, p<0.001; S2 Table). Given the significant distributional difference between estrous cycle stages (irrespective of the 5-Htt-genotype) and the fact that proestrus female mice (with overall highest estrogen levels) are less anxious than females in the other estrous phases [67], mice were classified into two groups (proestrus vs. other stages) for subsequent analyses.
Estrous cycle stage affects odor-induced perfusion level in the amygdala of female mice
Statistical results are summarized in S3 Table. Three-way mixed ANOVA on amygdala perfusion in female mice yielded a strong main effect of phase (F(2,44) = 26.388, p<0.0001) along with a phase x estrous cycle interaction (F(2,44) = 5.367, p = 0.009). Neither RS nor PS perfusion differed among estrous cycle groups (F(1,22) = 0.025, p = 0.876 and F(1,22) = 0.072, p = 0.791, respectively), while SS perfusion was significantly diminished in proestrus females relative to mice in other estrous stages (F(1,22) = 6.044, p = 0.022) (Fig 5A). This effect could be explained by a stronger increase in amygdala perfusion during odor exposure (RS→SS) in non-proestrus mice (p<0.0001) as compared to proestrus mice (p = 0.002). Furthermore, PS perfusion decreased significantly from SS levels (SS→PS) in non-proestrus females (p = 0.026) but remained elevated in proestrus mice (p = 1) (Fig 5A). Accordingly, when amygdala perfusion levels of the distinct fMRI phases were expressed as a fraction of one another (SS/RS, PS/RS, PS/SS), two-way ANOVA yielded the expected estrous cycle effect on SS/RS (F(1,22) = 6.978, p = 0.015; proestrus<other stages) (Fig 5C) and PS/SS (F(1,22) = 8.358, p = 0.008; proestrus>other stages) (Fig 5D) but not on PS/RS (F(1,22) = 0.045, p = 0.835). Similar results were obtained for whole-brain perfusion, though the effects were much less pronounced. Contrary to males, 5-Htt genotype exerted no significant effects in females, neither on RS perfusion nor on rat odor-induced perfusion level changes in both ROIs (Amygdala: Fig 5B, whole brain: S2 Fig).
Finally, neither the genotype x estrous cycle interaction nor the interaction between these two factors and phase on both whole-brain and local amygdala perfusion levels were statistically significant, thereby demonstrating that the observed estrous cycle effects on stimulus-induced perfusion changes were comparable across 5-Htt genotypes (S3 Table).
The number of c-Fos-ir cells in the amygdala of females appear to be highest in 5-HTT +/+ animals (S3 Fig). However, due to the small sample size of investigated females (n = 6) and the potential influence of their estrous cycle stage it is impossible to draw any valid conclusions.
Discussion
We applied a CASL method of non-invasive ultra-high field perfusion MRI to analyse baseline perfusion levels and perfusion level changes in response to aversive odor in a coronal plane containing the amygdala, the predominant region for fear processing. We analysed female as well as male mice of all three 5-Htt genotypes. Subsequently performed c-Fos immunohistochemistry study served to demonstrate activation at cellular level.
Since the odor of rats is known to evoke fear in mice [35,36,38,39,68–70], and that predator odors evoke an increase in c-Fos expression levels in different amygdala nuclei (as demonstrated by increased number of c-Fos-positive cells [40–42], we assumed that a higher amygdala activation may become apparent after the presentation of the odor of rat soiled bedding as an aversive stimulus, even if the mice were under anesthetic. Previous work has shown the capability of several aversive odors including predator urine volatiles to evoke responses in the brain of anesthetized mice [71–74]. As in our study in all experimental animals amygdala and total brain perfusion levels increased from RS to SS this assumption seemed to be right. Furthermore, as we detected more c-Fos-ir cells in the amygdala of mice exposed to the aversive rat odor than in mice exposed to neutral odor, what we show qualitatively, we conclude that rat odor is experienced as aversive by anaesthetized mice during fMRI. We assume that in association with the general perfusion increase the applied aversive rat odor represents a scent experience of special quality resulting in sustained activation of neurons. This is represented by the long-lasting high perfusion levels in male mice of all three 5-Htt genotypes even after termination of aversive odor presentation as well as by an increased amount of c-Fos-ir cells.
An influence of 5-Htt genotype on amygdala perfusion was revealed exclusively in male animals, with 5-HTT+/- mice exhibiting significantly higher RS perfusion levels compared to 5-HTT+/+ animals. In previous human studies also applying the CASL-method S-allele carriers, which may be best comparable to 5-HTT+/- mice with lower, but not completely absent 5-HTT protein levels, were shown to have an increased RS CBF compared to L-allele carriers (best comparable to 5-HTT+/+ mice) in the amygdala, but not in global brain [46,47]. These human studies revealed RS perfusion differences analyzing probands of both sexes. As, in contrast, Viviani and coworkers did not reveal an association between the 5-HTTLPR polymorphism and baseline brain perfusion in a cohort of healthy individuals applying CASL [48], we think that our study is of importance.
While mice of all three 5-Htt genotypes reached approximately the same perfusion levels during SS and PS, male 5-HTT+/+ mice showed a significantly higher percental perfusion level change from RS to SS (and PS) than 5-HTT+/- and 5-HTT-/- mice. These findings correspond to the increased density of c-Fos-ir cells in 5-HTT+/+ mice compared to 5-HTT+/- and -/- mice in all three amygdaloid nuclei. Correlation analysis provided evidence for a relationship of c-Fos-ir cell densities with perfusion level changes from RS to SS (and with a bit weaker significance from RS to PS). For a comprehensive interpretation of these correlation results one has to consider that the transcription factor c-Fos is shown to be differently regulated in individual brain regions, is discussed to be differently regulated in inhibitory and excitatory neurons, and that the time course of the induction and decay of Fos depends on the kind and strength of the stimulus itself [45,75,76]. Some brain regions seem to express no c-Fos at all despite various treatments [44]. Since the significance levels of our correlation analyses are not very different between Ce, a region with a high density of inhibitory neurons, and La, a region with a lower density of inhibitory neurons, we assume that the results of these correlation analyses do not reflect the type and composition of the amygdaloid nuclei analyzed. Therefore, there is currently no reason to doubt the validity of a positive correlation between c-Fos-positive cells and SS/RS perfusion. However, since the use of transcription inhibitors can block long-term synaptic plasticity [77], which is associated with changes in the expression of IEGs and their downstream genes, it would make sense to investigate in a future experiment whether the use of transcription inhibitors is able to reduce changes in perfusion levels from RS to SS shown in this study. This would highlight the physiological nature of c-Fos induction in relation to blood flow changes.
These lower perfusion level changes from RS to SS/PS in 5-HTT-/- and 5-HTT+/- mice than in 5-HTT+/+ controls are reminiscent of findings concerning stress-induced variations in the spine density of BLA pyramidal neurons, a morphological correlate of amygdala neuronal excitability, in male 5-HTT+/+ and 5-HTT-/- mice [78]. The fact that under basal conditions spine density in 5-HTT+/+ mice was significantly lower than in 5-HTT-/- mice, and stress experience induced spinogenesis in 5-HTT+/+ to the level of non-stressed 5-HTT-/- mice but failed to further increase spine density in 5-HTT-/- mice, can be interpreted as a “ceiling” effect. Diminished increase in amygdala perfusion upon predator odor and lack of stress-induced spinogenesis in 5-HTT-deficient mice suggest a dysfunction of neuroadaptive mechanisms that are meant to enable coping with aversive stimuli and also supports the “tonic model” of 5-HTTLPR function first suggested by Canli and Lesch in 2007 [5].
In contrast to the results with using males, females miss a clear effect of the 5-Htt genotype on the level of amygdala perfusion.
Female mice were shown to be in different estrous stages during the experiment. Although the group size of particular estrous stage groups was rather small, a significant interaction between estrous stage and fMRI phase became statistically discernable in whole brain perfusion measurements, which was even stronger in amygdala measurements. Proestrus females (with high estrogen/progesterone levels) showed a lower increase in perfusion during odor exposure relative to non-proestrus mice. As several studies demonstrated that females in the high-estrogen proestrus phase exhibited low anxiety-levels [67], less fear and a stronger fear extinction [79,80], as well as reduced neural activity in the bed nucleus of stria terminalis in response to an innate fear-inducing stimulus than females in low-estrogen phases [81] we can assume that the low SS perfusion levels we detected in our proestrous-staged mice indicate low anxiety levels of these mice.
Furthermore, PS perfusion levels did not differ significantly from SS levels in male mice (irrespective of the 5-Htt genotype). This missing reduction of CBF during PS in male mice could be the result of a long-lasting elevation of extracellular 5-HT levels after fearful experiences, reaching their maximum approximately 30–40 min after stimulus presentation with only a slow decrease to baseline levels [82,83]. Long-lasting high extracellular 5-HT levels in the amygdala could keep them in an activated status. In order to reveal a decrease of perfusion levels during PS an extension of CBF measurement during this fMRI state would be helpful.
In contrast to the results with male mice, in (low-estrogen) non-proestrus female mice PS perfusion levels decreased significantly from SS, but remained elevated like in male animals in (high-estrogen) proestrus females. Beside the variability and the influence of the estrous stage within the female group, the sex-specific processing of social cues could explain the differences between the results of both sexes. Male and female mice differently respond to the same stimuli presumably resulting in contrary behavioral output [84,85]. In general, obvious sex differences in rodents exist that influence 5-HT modulation in the amygdala, potentially derived from differential 5-HT receptor expression [86], varying 5-HT levels, extracellular [87] as well as in amygdala tissue extracts [88], both in neutral and stressful conditions. In summary, these obvious differences between males and females point to sex differences in fear processing in which the amygdala is involved.
Interestingly, the density of c-Fos-ir cells was ten times higher in the Ce compared to the La and BL in male as well as in female mice independent of their 5-Htt genotype. The Ce, which is–in contrast to the BLA with appr. 80% glutamatergic neurons—mainly comprised of GABAergic neurons, forms connections to brain areas, including the periaqueductal grey [89,90], that mediate defensive behaviors and regulate fear responses [23]. Vice versa 5-HT fibres in the La, BL and Ce mainly orginate in dorsal raphe neurons (DRNs) [25,27,91–93], a part of the periaqueductal grey, and sparsely from median raphe neurons [26,27,29]. These 5-HT innervations originating in DRNs are known to modulate the amygdaloid microcircuitry encoding the fear response after negative stimuli. Assuming that 5-HTT+/+ mice display lower and 5-HTT-/- mice higher fear and anxiety-like behaviors, the critical role of the 5-HTT in the underlying mechanisms is undoubted.
As in all three amygaloid nuclei c-Fos-ir cell densities post mortem (but also percental perfusion change from RS to SS during MRI) were significantly increased in 5-HTT+/+ compared to 5-HTT+/- and 5-HTT-/- mice the question for the cell type responsible for this increased amygdala activation emerges, e.g. the ratio between c-Fos-positive glutamatergic and GABAergic cells in the BLA would be of great interest. Presumably, 5-Htt-genotype dependent alterations in the local inhibitory circuits with consequences on the amygdaloid output could be one approach to explain behavioral differences between mice of various 5-Htt-genotypes [15,17,18,94].
In contrast to the results of our mouse fMRI study, it was reported that human S-allele carriers show amygdala hyperreactivity in response to the presentation of angry and fearful faces [49–55] suggesting 5-HTTLPR-dependent differences in face processing [95–99]. Therefore, our results of exaggerated increase of CBF levels from RS to SS in 5-HTT+/+ mice, and not in 5-HTT+/- and -/- mice, seem at first to be contradictory. However, this exaggerated increase of CBF levels from RS to SS in 5-HTT+/+ mice, and not in 5-HTT+/- and -/- mice, is supported by the tonic activation model of 5-HTTLPR function suggested by Canli and coworkers [46,51], for review: [5]), but not by the standard phasic activation model of 5-HTTLPR function. Tonic firing of 5-HT neuron population activity seems related to the extra-synaptic tonic 5-HT levels and phasic firing activity to the rapid, high-amplitude, and intra-synaptic 5-HT release.The tonic model assumes lower RS baseline perfusion levels for LL-allele carriers relative to S-allele carriers. Perfusion imaging data obtained by Canli and coworkers exactly confirmed this assumption of elevated baseline amygdala activation levels of 5-HTTLPR S-allele carriers compared with LL-allele carriers [46], and fit to the results of this study. However, this does not preclude the amygdala of S-allele carriers from reacting to stress with a strong phasic response on top of its elevated baseline levels [5]. Moreover, a ceiling effect is suggested as the maximal activation level observed in the amygdala during the SS condition is not different between mice of all three 5-Htt genotypes. Therefore, it is necessary that the change from RS to that ceiling (SS) level is much larger for 5-HTT+/+ than for 5-HTT+/- mice, as they start from a lower resting baseline.
Beyond that, several differences of the human and rodent study designs, e.g. different natures of stimuli and different techniques and ways of analysis, have to be taken into account, which renders direct comparisons difficult. Different natures of stimuli are processed through different networks including the amygdala, and the role of the amygdala seems to be different in either case. During face processing the amygdala is triggering gaze changes towards diagnostically relevant facial features, which is shown to be modulated by the 5-HTTLPR [97]. In contrast, in our study the role of the amygdala is in the processing of the threatening odor of a predator. Regarding different methodologies, BOLD-contrast imaging in human studies enables a time-related resolution of seconds [100]. In our study we applied a CASL method [57] similar to the ASL method Canli and coworkers applied in her human study from 2006 [46]. Based on our setup and parameters, the particular measurements for RS, SS and PS lasted 20–30 min, with the scope of long-term perfusion levels and long-term effects of stimulations.
To our knowledge, we were the first to show a correlation between the signal change of perfusion levels in a brain region and the density of c-Fos-ir cells in the same region post mortem. This suggests that the perfusion level increase in a distinct brain region derives from an accumulation of cell populations being activated, supporting the use of c-Fos-detection as a marker for neuronal activity. Moreover, the present study contributes to the findings that the 5-Htt/5-HTT genotype modulates fear and anxiety-like behaviors after aversive stimuli by means of differential activation of the amygdala, at least in male mice. Furthermore, we were the first demonstrating sex differences in amygdala perfusion levels after the exposure to an aversive rat odor, and that estrous levels seem to have a tremendous influence on the activity of the amygdala. Last but not least, we provide an important contribution to the controversial discussion on the topic “phasic and/or tonic model of 5-HTTLPR function” in the human imaging literature. Nevertheless, our results support the notion that fMRI investigations are an appropriate tool to study brain activation patterns in the field of fear and anxiety research, but also in other research fields.
Supporting information
Acknowledgments
Special thanks go to Sabine Voll, Marion Winnig, and Eva-Kristin Broschk for excellent technical assistance.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This work was funded by the German Research Foundation (DFG; https://www.dfg.de/), grant number 44541416: Collaborative Research Centre/Transregio 58 (CRC-TRR58), subproject A1 to KPL and subproject A5 to KPL and ASB. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
References
- 1.Lesch KP, Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29: 1062–73. 10.1016/j.pnpbp.2005.03.012 [DOI] [PubMed] [Google Scholar]
- 2.Kugaya A, Seneca NM, Snyder PJ, Williams SA, Malison RT, Baldwin RM, et al. Changes in humanin vivoserotonin and dopamine transporter availabilities during chronic antidepressantadministration. Neuropsychopharmacology. 2003;28: 413–420. 10.1038/sj.npp.1300036 [DOI] [PubMed] [Google Scholar]
- 3.Olivier JDA, Vinkers CH, Olivier B. The role of the serotonergic and GABA system in translational approaches in drug discovery for anxiety disorders. Frontiers in Pharmacology. Frontiers Media SA; 2013. p. 74 10.3389/fphar.2013.00074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274: 1527–1531. 10.1126/science.274.5292.1527 [DOI] [PubMed] [Google Scholar]
- 5.Canli T, Lesch K-P. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci. 2007;10: 1103–9. 10.1038/nn1964 [DOI] [PubMed] [Google Scholar]
- 6.Homberg JR, Lesch K-P. Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry. 2011;69: 513–9. 10.1016/j.biopsych.2010.09.024 [DOI] [PubMed] [Google Scholar]
- 7.Homberg JR, Schubert D, Asan E, Aron EN. Sensory processing sensitivity and serotonin gene variance: Insights into mechanisms shaping environmental sensitivity. Neuroscience and Biobehavioral Reviews. 2016. pp. 472–483. 10.1016/j.neubiorev.2016.09.029 [DOI] [PubMed] [Google Scholar]
- 8.Hu X-Z, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78: 815–26. 10.1086/503850 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter-deficient mice. Mol Pharmacol. 1998;53: 649–55. 10.1124/mol.53.4.649 [DOI] [PubMed] [Google Scholar]
- 10.Gobbi G, Murphy D, Lesch K, Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol. 2001;296: 987–995. [PubMed] [Google Scholar]
- 11.Li Q, Wichems CH, Ma L, Van de Kar LD, Garcia F, Murphy DL. Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J Neurochem. 2003;84: 1256–1265. 10.1046/j.1471-4159.2003.01607.x [DOI] [PubMed] [Google Scholar]
- 12.Fabre V, Beaufour C, Evrard A, Rioux A, Hanoun N, Lesch KP, et al. Altered expression and functions of serotonin 5-HT 1A and 5-HT 1B receptors in knock-out mice lacking the 5-HT transporter. Neuroscience. 2000;12: 2299–2310. Available: http://www.molecularpsychiatry.uk-wuerzburg.de/fileadmin/uk/molecularpsychiatry/PDFs/2000/Fabreetal.00.pdf. [DOI] [PubMed] [Google Scholar]
- 13.Shen HW, Hagino Y, Kobayashi K, Shinohara-Tanaka K, Ikeda K, Yamamoto H, et al. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. Neuropsychopharmacology. 2004;29: 1790–1799. 10.1038/sj.npp.1300476 [DOI] [PubMed] [Google Scholar]
- 14.Mathews TA, Fedele DE, Coppelli FM, Avila AM, Murphy DL, Andrews AM. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression Journal of Neuroscience Methods. Elsevier; 2004. pp. 169–181. 10.1016/j.jneumeth.2004.05.017 [DOI] [PubMed] [Google Scholar]
- 15.Holmes A, Li Q, Murphy DL, Gold E, Crawley JN. Abnormal anxiety-related behaviour in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav. 2003;2: 365–380. 10.1046/j.1601-1848.2003.00050.x [DOI] [PubMed] [Google Scholar]
- 16.Holmes A, Yang RJ, Lesch K-P, Crawley JN, Murphy DL. Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology. 2003;28: 2077–2088. 10.1038/sj.npp.1300266 [DOI] [PubMed] [Google Scholar]
- 17.Murphy DL, Lesch KP. Targeting the murine serotonin transporter: Insights into human neurobiology. Nature Reviews Neuroscience. 2008. pp. 85–96. 10.1038/nrn2284 [DOI] [PubMed] [Google Scholar]
- 18.Karabeg MM, Grauthoff S, Kollert SY, Weidner M, Heiming RS, Jansen F, et al. 5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze. PLoS One. 2013;8: e78238 10.1371/journal.pone.0078238 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Carroll JC, Boyce-Rustay JM, Millstein R, Yang R, Wiedholz LM, Murphy DL, et al. Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice. Behav Genet. 2007;37: 214–222. 10.1007/s10519-006-9129-9 [DOI] [PubMed] [Google Scholar]
- 20.Heiming RS, Sachser N. Consequences of serotonin transporter genotype and early adversity on behavioral profile—pathology or adaptation? Frontiers in Neuroscience. 2010. 10.3389/fnins.2010.00187 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Bodden C, Richter SH, Schreiber RS, Kloke V, Gerß J, Palme R, et al. Benefits of adversity?! How life history affects the behavioral profile of mice varying in serotonin transporter genotype. Front Behav Neurosci. 2015;9: 47 10.3389/fnbeh.2015.00047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Adamec R, Burton P, Blundell J, Murphy DL, Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res. 2006;170: 126–140. 10.1016/j.bbr.2006.02.012 [DOI] [PubMed] [Google Scholar]
- 23.Tovote P, Fadok JP, Luthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015;16: 317–331. 10.1038/nrn3945 [DOI] [PubMed] [Google Scholar]
- 24.Dogra N, Lunn B, Cooper S. Psychiatry by ten teachers, second edition Psychiatry by Ten Teachers, Second Edition Nature Publishing Group; 2017. 10.1201/9781315380612 [DOI] [Google Scholar]
- 25.Vertes RP. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol. 1991;313: 643–668. 10.1002/cne.903130409 [DOI] [PubMed] [Google Scholar]
- 26.Vertes RP, Fortin WJ, Crane AM. Projections of the median raphe nucleus in the rat. J Comp Neurol. 1999;407: 555–582. [DOI] [PubMed] [Google Scholar]
- 27.Muzerelle A, Scotto-Lomassese S, Bernard JF, Soiza-Reilly M, Gaspar P. Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5–B9) to the forebrain and brainstem. Brain Struct Funct. 2016;221: 535–561. 10.1007/s00429-014-0924-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.McDonald AJ. Neurons of the Lateral and Basolateral Amygdaloid Nuclei: A Golgi Study in the Rat. J Comp Neurol. 1982;312: 293–312. 10.1002/cne.902120307 [DOI] [PubMed] [Google Scholar]
- 29.Asan E, Steinke M, Lesch KP. Serotonergic innervation of the amygdala: Targets, receptors, and implications for stress and anxiety. Histochemistry and Cell Biology. 2013. pp. 785–813. 10.1007/s00418-013-1081-1 [DOI] [PubMed] [Google Scholar]
- 30.Stowers L, Logan DW. Olfactory mechanisms of stereotyped behavior: on the scent of specialized circuits. Current Opinion in Neurobiology. 2010. pp. 274–280. 10.1016/j.conb.2010.02.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Root CM, Denny CA, Hen R, Axel R. The participation of cortical amygdala in innate, odour-driven behaviour. Nature. 2014;515: 269–273. 10.1038/nature13897 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Thompson JA, Salcedo E, Restrepo D, Finger TE. Second-order input to the medial amygdala from olfactory sensory neurons expressing the transduction channel TRPM5. J Comp Neurol. 2012;520: 1819–1830. 10.1002/cne.23015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Keshavarzi S, Power JM, Albers EHH, Sullivan RKS, Sah P. Dendritic Organization of Olfactory Inputs to Medial Amygdala Neurons. J Neurosci. 2015;35: 13020–13028. 10.1523/JNEUROSCI.0627-15.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Brennan PA, Zufall F. Pheromonal communication in vertebrates. Nature. 2006;444: 308–315. 10.1038/nature05404 [DOI] [PubMed] [Google Scholar]
- 35.Calvo-Torrent A, Brain PF, Martinez M. Effect of predatory stress on sucrose intake and behavior on the plus-maze in male mice. Physiol Behav. 1999;67: 189–196. 10.1016/s0031-9384(99)00051-7 [DOI] [PubMed] [Google Scholar]
- 36.Yang M, Augustsson H, Markham CM, Hubbard DT, Webster D, Wall PM, et al. The rat exposure test: A model of mouse defensive behaviors. Physiol Behav. 2004;81: 465–473. 10.1016/j.physbeh.2004.02.010 [DOI] [PubMed] [Google Scholar]
- 37.Apfelbach R, Blanchard CD, Blanchard RJ, Hayes RA, McGregor IS. The effects of predator odors in mammalian prey species: A review of field and laboratory studies Neuroscience and Biobehavioral Reviews. Pergamon; 2005. pp. 1123–1144. 10.1016/j.neubiorev.2005.05.005 [DOI] [PubMed] [Google Scholar]
- 38.Banik A, Anand A. Loss of learning in mice when exposed to rat odor: A water maze study. Behav Brain Res. 2011;216: 466–471. 10.1016/j.bbr.2010.07.035 [DOI] [PubMed] [Google Scholar]
- 39.Campos KFC, Amaral VCS, Rico JL, Miguel TT, Nunes-de-Souza RL. Ethopharmacological evaluation of the rat exposure test: A prey-predator interaction test. Behav Brain Res. 2013;240: 160–170. 10.1016/j.bbr.2012.11.023 [DOI] [PubMed] [Google Scholar]
- 40.Asok A, Ayers LW, Awoyemi B, Schulkin J, Rosen JB. Immediate early gene and neuropeptide expression following exposure to the predator odor 2,5-dihydro-2,4,5-trimethylthiazoline (TMT). Behav Brain Res. 2013;248: 85–93. 10.1016/j.bbr.2013.03.047 [DOI] [PubMed] [Google Scholar]
- 41.Sotnikov S V., Chekmareva NY, Schmid B, Harbich D, Malik V, Bauer S, et al. Enriched environment impacts trimethylthiazoline-induced anxiety-related behavior and immediate early gene expression: Critical role of Crhr1. Eur J Neurosci. 2014;40: 2691–2700. 10.1111/ejn.12624 [DOI] [PubMed] [Google Scholar]
- 42.Weera MM, Schreiber AL, Avegno EM, Gilpin NW. The role of central amygdala corticotropin-releasing factor in predator odor stress-induced avoidance behavior and escalated alcohol drinking in rats. Neuropharmacology. 2020;166: 107979 10.1016/j.neuropharm.2020.107979 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Schwartz WJ, Smith CB, Davidsen L, Savaki H, Sokoloff L, Mata M, et al. Metabolic mapping of functional activity in the hypothalamo- neurohypophysial system of the rat. Science (80-). 1979;205: 723–725. 10.1126/science.462184 [DOI] [PubMed] [Google Scholar]
- 44.Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods. 1989;29: 261–265. 10.1016/0165-0270(89)90150-7 [DOI] [PubMed] [Google Scholar]
- 45.Kovács KJ. Measurement of Immediate-Early Gene Activation- c-fos and Beyond. J Neuroendocrinol. 2008;20: 665–672. 10.1111/j.1365-2826.2008.01734.x [DOI] [PubMed] [Google Scholar]
- 46.Canli T, Qiu M, Omura K, Congdon E, Haas BW, Amin Z, et al. Neural correlates of epigenesis. Proc Natl Acad Sci. 2006;103: 16033–16038. 10.1073/pnas.0601674103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Rao H, Gillihan SJ, Wang J, Korczykowski M, Sankoorikal GM V, Kaercher KA, et al. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol Psychiatry. 2007;62: 600–6. 10.1016/j.biopsych.2006.11.028 [DOI] [PubMed] [Google Scholar]
- 48.Viviani R, Sim EJ, Lo H, Beschoner P, Osterfeld N, Maier C, et al. Baseline Brain Perfusion and the Serotonin Transporter Promoter Polymorphism. Biol Psychiatry. 2010;67: 317–322. 10.1016/j.biopsych.2009.08.035 [DOI] [PubMed] [Google Scholar]
- 49.Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, et al. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297: 400–3. 10.1126/science.1071829 [DOI] [PubMed] [Google Scholar]
- 50.Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, et al. A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala. Arch Gen Psychiatry. 2005;62: 146 10.1001/archpsyc.62.2.146 [DOI] [PubMed] [Google Scholar]
- 51.Canli T, Omura K, Haas BW, Fallgatter A, Constable RT, Lesch KP. Beyond affect: A role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc Natl Acad Sci. 2005;102: 12224–12229. 10.1073/pnas.0503880102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Munafò MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry. 2008;63: 852–7. 10.1016/j.biopsych.2007.08.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Heinz A, Smolka MN, Braus DF, Wrase J, Beck A, Flor H, et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry. 2007;61: 1011–4. 10.1016/j.biopsych.2006.08.019 [DOI] [PubMed] [Google Scholar]
- 54.Hariri AR, Holmes A. Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci. 2006;10: 182–91. 10.1016/j.tics.2006.02.011 [DOI] [PubMed] [Google Scholar]
- 55.Hariri AR, Drabant EM, Weinberger DR. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry. 2006;59: 888–97. 10.1016/j.biopsych.2005.11.005 [DOI] [PubMed] [Google Scholar]
- 56.Brockmann H, Zobel A, Schuhmacher A, Daamen M, Joe A, Biermann K, et al. Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J Psychiatr Res. 2011;45: 442–451. 10.1016/j.jpsychires.2010.08.016 [DOI] [PubMed] [Google Scholar]
- 57.Alsop D, Detre J. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. Eur J Radiol. 1999;30: 115–124. 10.1016/s0720-048x(99)00050-9 [DOI] [PubMed] [Google Scholar]
- 58.McLean AC, Valenzuela N, Fai S, Bennett SAL. Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification. J Vis Exp. 2012 [cited 13 Jan 2018]. 10.3791/4389 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23: 37–45. 10.1002/mrm.1910230106 [DOI] [PubMed] [Google Scholar]
- 60.Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89: 212–6. 10.1073/pnas.89.1.212 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Wong EC, Buxton RB, Frank LR. A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med. 1998;40: 348–355. 10.1002/mrm.1910400303 [DOI] [PubMed] [Google Scholar]
- 62.Pham M, Helluy X, Braeuninger S, Jakob P, Stoll G, Kleinschnitz C, et al. Outcome of experimental stroke in C57Bl/6 and Sv/129 mice assessed by multimodal ultra-high field MRI. Exp Transl Stroke Med. 2010;2: 6 10.1186/2040-7378-2-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Pham M, Helluy X, Kleinschnitz C, Kraft P, Bartsch AJ, Jakob P, et al. Sustained reperfusion after blockade of glycoprotein-receptor-IB in focal cerebral ischemia: An MRI study at 17.6 Tesla. PLoS One. 2011;6 10.1371/journal.pone.0018386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Watson C, Paxinos G. Paxinos and Franklin’s the Mouse Brain in Stereotaxic Coordinates, Fourth Edition The Spinal Cord: A Christopher and Dana Reeve Foundation Text and Atlas; 2012. [Google Scholar]
- 65.Periaswamy S, Farid H. Elastic Registration with Partial Data Biomedical Image Registration. Springer, Berlin, Heidelberg; 2003. pp. 102–111. 10.1007/978-3-540-39701-4_11 [DOI] [Google Scholar]
- 66.Periaswamy S, Farid H. Medical image registration with partial data. Med Image Anal. 2006;10: 452–464. 10.1016/j.media.2005.03.006 [DOI] [PubMed] [Google Scholar]
- 67.Walf AA, Koonce C, Manley K, Frye CA. Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res. 2009;196: 254–260. 10.1016/j.bbr.2008.09.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Molina V, Ciesielski L, Gobaille S, Isel F, Mandel P. Inhibition of mouse killing behavior by serotonin-mimetic drugs: Effects of partial alterations of serotonin neurotransmission. Pharmacol Biochem Behav. 1987;27: 123–131. 10.1016/0091-3057(87)90486-2 [DOI] [PubMed] [Google Scholar]
- 69.Huo Y, Fang Q, Shi Y-L, Zhang Y-H, Zhang J-X. Chronic exposure to a predator or its scent does not inhibit male-male competition in male mice lacking brain serotonin. Front Behav Neurosci. 2014;8: 116 10.3389/fnbeh.2014.00116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Liu YJ, Li LF, Zhang YH, Guo HF, Xia M, Zhang MW, et al. Chronic Co-species Housing Mice and Rats Increased the Competitiveness of Male Mice. Chem Senses. 2017;42: 247–257. 10.1093/chemse/bjw164 [DOI] [PubMed] [Google Scholar]
- 71.Stettler DD, Axel R. Representations of Odor in the Piriform Cortex. Neuron. 2009;63: 854–864. 10.1016/j.neuron.2009.09.005 [DOI] [PubMed] [Google Scholar]
- 72.Kass MD, Rosenthal MC, Pottackal J, McGann JP. Fear learning enhances neural responses to threat-predictive sensory stimuli. Science (80-). 2013;342: 1389–1392. 10.1126/science.1244916 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Dewan A, Pacifico R, Zhan R, Rinberg D, Bozza T. Non-redundant coding of aversive odours in the main olfactory pathway. Nature. 2013;497: 486–489. 10.1038/nature12114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Ross JM, Fletcher ML. Olfactory fear conditioning non-specifically enhances glomerular odor responses and increases representational overlap of learned and neutral odors. 2017. [cited 12 Jan 2018]. 10.1101/194415 [DOI] [Google Scholar]
- 75.Staiger JF, Masanneck C, Bisler S, Schleicher A, Zuschratter W, Zilles K. Excitatory and inhibitory neurons express c-Fos in barrel-related columns after exploration of a novel environment. Neuroscience. 2002;109: 687–699. 10.1016/s0306-4522(01)00501-2 [DOI] [PubMed] [Google Scholar]
- 76.Robins MT, Li J, Ryabinin AE. Effects of Housing Conditions and Circadian Time on Baseline c-Fos Immunoreactivity in C57BL/6J Mice. Neuroscience. 2020;431: 143–151. 10.1016/j.neuroscience.2020.02.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Frey U, Frey S, Schollmeier F, Krug M. Influence of actinomycin D, a RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro. J Physiol. 1996;490: 703–711. 10.1113/jphysiol.1996.sp021179 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Nietzer SL, Bonn M, Jansen F, Heiming RS, Lewejohann L, Sachser N, et al. Serotonin transporter knockout and repeated social defeat stress: Impact on neuronal morphology and plasticity in limbic brain areas. Behav Brain Res. 2011;220: 42–54. 10.1016/j.bbr.2011.01.011 [DOI] [PubMed] [Google Scholar]
- 79.Milad MR, Igoe SA, Lebron-Milad K, Novales JE. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience. 2009;164: 887–895. 10.1016/j.neuroscience.2009.09.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Maeng LY, Cover KK, Landau AJ, Milad MR, Lebron-Milad K. Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats. J Vis Exp. 2015. [cited 13 Jan 2018]. 10.3791/52202 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Chen W, Shields J, Huang W, King JA. Female fear: Influence of estrus cycle on behavioral response and neuronal activation. Behav Brain Res. 2009;201: 8–13. 10.1016/j.bbr.2009.01.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Yokoyama M, Suzuki E, Sato T, Maruta S, Watanabe S, Miyaoka H. Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett. 2005;379: 37–41. 10.1016/j.neulet.2004.12.047 [DOI] [PubMed] [Google Scholar]
- 83.Zanoveli JM, Carvalho MC, Cunha JM, Brandão ML. Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: An in vivo microdialysis study. Brain Res. 2009;1294: 106–115. 10.1016/j.brainres.2009.07.074 [DOI] [PubMed] [Google Scholar]
- 84.Bergan JF, Ben-Shaul Y, Dulac C. Sex-specific processing of social cues in the medial amygdala. Elife. 2014;3: e02743 10.7554/eLife.02743 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Li Y, Dulac C. Neural coding of sex-specific social information in the mouse brain. Current Opinion in Neurobiology. 2018. pp. 120–130. 10.1016/j.conb.2018.07.005 [DOI] [PubMed] [Google Scholar]
- 86.Zhang L, Ma W, Barker JL, Rubinow DR. SEX DIFFERENCES IN EXPRESSION OF SEROTONIN RECEPTORS (SUBTYPES 1A AND 2A) IN RAT BRAIN: A POSSIBLE ROLE OF TESTOSTERONE. Neuroscience. 1999;94: 251–259. 10.1016/s0306-4522(99)00234-1 [DOI] [PubMed] [Google Scholar]
- 87.Mitsushima D, Yamada K, Takase K, Funabashi T, Kimura F. Sex differences in the basolateral amygdala: the extracellular levels of serotonin and dopamine, and their responses to restraint stress in rats. Eur J Neurosci. 2006;24: 3245–3254. 10.1111/j.1460-9568.2006.05214.x [DOI] [PubMed] [Google Scholar]
- 88.Duchesne A, Dufresne MM, Sullivan RM. Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling. Prog Neuro-Psychopharmacology Biol Psychiatry. 2009;33: 251–261. 10.1016/j.pnpbp.2008.11.012 [DOI] [PubMed] [Google Scholar]
- 89.Johansen JP, Tarpley JW, Ledoux JE, Blair HT. Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray. Nat Neurosci. 2010;13: 979–986. 10.1038/nn.2594 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Tovote P, Esposito MS, Botta P, Chaudun F, Fadok JP, Markovic M, et al. Midbrain circuits for defensive behaviour. Nature. 2016;534: 206–212. 10.1038/nature17996 [DOI] [PubMed] [Google Scholar]
- 91.Jacobs BL, Foote SL, Bloom FE. Differential projections of neurons within the dorsal raphe nucleus of the rat: a horseradish peroxidase (HRP) study. Brain Res. 1978;147: 149–153. 10.1016/0006-8993(78)90779-5 [DOI] [PubMed] [Google Scholar]
- 92.Abrams JK, Johnson PL, Hollis JH, Lowry CA. Anatomic and functional topography of the dorsal raphe nucleus Annals of the New York Academy of Sciences. Blackwell Publishing Ltd; 2004. pp. 46–57. 10.1196/annals.1296.005 [DOI] [PubMed] [Google Scholar]
- 93.Halberstadt AL, Balaban CD. Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus. Neuroscience. 2006;140: 1067–1077. 10.1016/j.neuroscience.2006.02.053 [DOI] [PubMed] [Google Scholar]
- 94.Holmes A, Yang RJ, Lesch K-P, Crawley JN, Murphy DL. Mice Lacking the Serotonin Transporter Exhibit 5-HT1A Receptor-Mediated Abnormalities in Tests for Anxiety-like Behavior. Neuropsychopharmacology. 2003. [cited 6 Feb 2018]. 10.1038/sj.npp.1300266 [DOI] [PubMed] [Google Scholar]
- 95.von dem Hagen EAH, Passamonti L, Nutland S, Sambrook J, Calder AJ. The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional faces. Neuropsychologia. 2011;49: 674–680. 10.1016/j.neuropsychologia.2010.12.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Koizumi A, Kitagawa N, Kondo HM, Kitamura MS, Sato T, Kashino M. Serotonin Transporter Gene-Linked Polymorphism Affects Detection of Facial Expressions. PLoS One. 2013;8 10.1371/journal.pone.0059074 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Boll S, Gamer M. 5-HTTLPR modulates the recognition accuracy and exploration of emotional facial expressions. Front Behav Neurosci. 2014;8: 255 10.3389/fnbeh.2014.00255 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Hildebrandt A, Kiy A, Reuter M, Sommer W, Wilhelm O. Face and emotion expression processing and the serotonin transporter polymorphism 5-HTTLPR/rs22531. Genes, Brain Behav. 2016;15: 453–464. 10.1111/gbb.12295 [DOI] [PubMed] [Google Scholar]
- 99.Velasquez F, Wiggins JL, Mattson WI, Martin DM, Lord C, Monk CS. The influence of 5-HTTLPR transporter genotype on amygdala-subgenual anterior cingulate cortex connectivity in autism spectrum disorder. Dev Cogn Neurosci. 2017;24: 12–20. 10.1016/j.dcn.2016.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Hennig J, Speck O, Koch MA, Weiller C. Functional magnetic resonance imaging: A review of methodological aspects and clinical applications. J Magn Reson Imaging. 2003;18: 1–15. 10.1002/jmri.10330 [DOI] [PubMed] [Google Scholar]